Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction

Description

The primary aim of this study is to collect and store data, tissue, and personal and family histories from patients being screened for colorectal cancer and/or endometrial cancer at NYPH and WCM for routine clinical care and to make these available for future use for molecular and mechanistic studies.

Conditions

Colorectal Cancer, Endometrial Cancer, Hereditary Cancer Syndromes

Talk to us

Study Overview

On this page

Study Details

Study overview

The primary aim of this study is to collect and store data, tissue, and personal and family histories from patients being screened for colorectal cancer and/or endometrial cancer at NYPH and WCM for routine clinical care and to make these available for future use for molecular and mechanistic studies.

Discovering New Targets for Hereditary and Sporadic Colorectal and Endometrial Cancer Risk Reduction

Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction

Condition
Colorectal Cancer
Intervention / Treatment

-

Contacts and Locations

New York

NYP/Weill Cornell Medicine, New York, New York, United States, 10065

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Diagnosis of a Hereditary Cancer Syndrome by positive genetic testing and/or clinical criteria to undergo an endoscopy procedure (esophagoduodenoscopy and/or colonoscopy/flexible sigmoidoscopy), or endometrial screening procedure (transvaginal ultrasound and/or hysteroscopy and/or endometrial biopsy), OR
  • * Individuals coming to Weill-Cornell Medicine/NYPH to undergo an endoscopy procedure, transvaginal ultrasound, or hysteroscopy for average-risk (population-based) recommendation OR
  • * Individuals diagnosed with colorectal cancer or endometrial cancer coming to Weill- Cornell Medicine/NYPH for surgical treatment OR
  • * Individuals coming to Weill-Cornell Medicine/NYPH for care such, as but not limited to, diagnostic testing, clinic and/or treatment visit.
  • * Willingness and ability to sign informed consent.
  • * Ability to read/understand English, Spanish, and/or simplified Chinese.
  • * Patients who are included in the NYPH CADC GI or have signed a waiver to include biospecimens in research studies at NYPH.
  • * under 18 years old
  • * does not meet criteria listed above

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Weill Medical College of Cornell University,

Steven M Lipkin, MD, PRINCIPAL_INVESTIGATOR, Weill Medical College of Cornell University

Study Record Dates

2026-12-31